BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22146786)

  • 21. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the 8th AJCC staging system for pathologically versus clinically staged pancreatic adenocarcinoma: A time to revisit a dogma?
    Abdel-Rahman O
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):64-69. PubMed ID: 29428107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system.
    Sun Y; Tang LL; Chen L; Li WF; Mao YP; Liu LZ; Lin AH; Li L; Ma J
    BMC Cancer; 2012 Feb; 12():68. PubMed ID: 22336097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of seventh edition AJCC gastric cancer staging modifications.
    Kim DH; Oh CA; Oh SJ; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
    J Surg Oncol; 2012 Jan; 105(1):26-30. PubMed ID: 21761411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
    Yang XL; Wang Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y
    BMC Cancer; 2018 May; 18(1):606. PubMed ID: 29843648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Classification of 3097 patients from the Japanese melanoma study database using the American joint committee on cancer eighth edition cancer staging system.
    Fujisawa Y; Yoshikawa S; Minagawa A; Takenouchi T; Yokota K; Uchi H; Noma N; Nakamura Y; Asai J; Kato J; Fujiwara S; Fukushima S; Uehara J; Hoashi T; Kaji T; Fujimura T; Namikawa K; Yoshioka M; Murata N; Ogata D; Matsuyama K; Hatta N; Shibayama Y; Fujiyama T; Ishikawa M; Yamada D; Kishi A; Nakamura Y; Shimiauchi T; Fujii K; Fujimoto M; Ihn H; Katoh N
    J Dermatol Sci; 2019 May; 94(2):284-289. PubMed ID: 31023613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of prognostic compatibility between seventh AJCC/TNM of the esophagus and 14th JCGC staging systems in Siewert type II adenocarcinoma.
    Kawaguchi T; Komatsu S; Ichikawa D; Kubota T; Okamoto K; Shiozaki A; Fujiwara H; Konishi H; Morimura R; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Sakakura C; Otsuji E
    Anticancer Res; 2013 Aug; 33(8):3461-5. PubMed ID: 23898120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the 6th and 7th editions of the AJCC/UICC TNM staging system for gastric cancer focusing on the "N" parameter-related survival: the monoinstitutional NodUs Italian study.
    Marano L; Boccardi V; Braccio B; Esposito G; Grassia M; Petrillo M; Pezzella M; Porfidia R; Reda G; Romano A; Schettino M; Cosenza A; Izzo G; Di Martino N
    World J Surg Oncol; 2015 Jul; 13():215. PubMed ID: 26179492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymph node ratio as determined by the 7th edition of the American Joint Committee on Cancer staging system predicts survival in stage III colon cancer.
    Hong KD; Lee SI; Moon HY
    J Surg Oncol; 2011 Apr; 103(5):406-10. PubMed ID: 21400524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The New American Joint Committee on Cancer/International Union Against Cancer staging system for adenocarcinoma of the stomach: increased complexity without clear improvement in predictive accuracy.
    Dikken JL; van de Velde CJ; Gönen M; Verheij M; Brennan MF; Coit DG
    Ann Surg Oncol; 2012 Aug; 19(8):2443-51. PubMed ID: 22618718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seventh edition (2010) of the AJCC/UICC staging system for gastric adenocarcinoma: is there room for improvement?
    Patel MI; Rhoads KF; Ma Y; Ford JM; Visser BC; Kunz PL; Fisher GA; Chang DT; Koong A; Norton JA; Poultsides GA
    Ann Surg Oncol; 2013 May; 20(5):1631-8. PubMed ID: 23149854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-world study of a novel prognostic scoring system: for a more precise prognostication and better clinical treatment guidance in stages II and III colon cancer.
    Liu Q; Ma Y; Luo D; Cai S; Li Q; Li X
    Int J Colorectal Dis; 2018 Aug; 33(8):1107-1114. PubMed ID: 29770845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of the American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma.
    Shin DW; Lee JC; Kim J; Woo SM; Lee WJ; Han SS; Park SJ; Choi KS; Cha HS; Yoon YS; Han HS; Hong EK; Hwang JH
    Eur J Surg Oncol; 2019 Nov; 45(11):2159-2165. PubMed ID: 31202572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of the seventh edition of the American Joint Committee on cancer tumor node-staging system in patients with colorectal carcinoma in comparison with sixth classification.
    Park JS; Choi GS; Hasegawa S; Sakai Y; Huh JW; Kim HR; Kwak SG
    J Surg Oncol; 2012 Nov; 106(6):674-9. PubMed ID: 22514036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the seventh edition of American Joint Committee on Cancer TNM staging system for gastric cancer: results from a Chinese monoinstitutional study.
    Sun Z; Wang ZN; Zhu Z; Xu YY; Xu Y; Huang BJ; Zhu GL; Xu HM
    Ann Surg Oncol; 2012 Jun; 19(6):1918-27. PubMed ID: 22246426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
    Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
    Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No significant difference in the prognostic value of the 5th and 7th editions of AJCC staging for differentiated thyroid cancer.
    Vrachimis A; Gerss J; Stoyke M; Wittekind C; Maier T; Wenning C; Rahbar K; Schober O; Riemann B
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):911-7. PubMed ID: 24417487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is the N1c category of the new American Joint Committee on cancer staging system applicable to patients with rectal cancer who receive preoperative chemoradiotherapy?
    Song JS; Chang HJ; Kim DY; Kim SY; Baek JY; Park JW; Park SC; Choi HS; Oh JH
    Cancer; 2011 Sep; 117(17):3917-24. PubMed ID: 21858800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of the Eighth AJCC New Substages for Bladder Cancer Among Different Staging Contexts.
    Abdel-Rahman O
    Clin Genitourin Cancer; 2017 Dec; 15(6):e1095-e1106. PubMed ID: 28843376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restaging of differentiated thyroid carcinoma by the sixth edition AJCC/UICC TNM staging system: stage migration and predictability.
    Lang B; Lo CY; Chan WF; Lam KY; Wan KY
    Ann Surg Oncol; 2007 May; 14(5):1551-9. PubMed ID: 17318278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.